Literature DB >> 8757146

Metronidazole-resistant H pylori--of questionable clinical importance.

R P Walt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8757146     DOI： 10.1016/s0140-6736(05)64665-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Helicobacter pylori.

Authors:  M C Bateson
Journal:  Postgrad Med J       Date:  2000-03       Impact factor: 2.401

2.  Subpopulations of Helicobacter pylori are responsible for discrepancies in the outcome of nitroimidazole susceptibility testing.

Authors:  E J van der Wouden; A de Jong; J C Thijs; J H Kleibeuker; A A van Zwet
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

3.  Quadruple therapy for symptomatic spontaneous duodenal ulcer disease.

Authors:  M C Bateson
Journal:  Postgrad Med J       Date:  2001-07       Impact factor: 2.401

4.  Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands.

Authors:  E J van der Wouden; A A van Zwet; G D Vosmaer; J A Oom; A de Jong; J H Kleibeuker
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883

Review 5.  Testing for Helicobacter pylori in primary care: trouble in store?

Authors:  R Foy; J M Parry; L Murray; C B Woodman
Journal:  J Epidemiol Community Health       Date:  1998-05       Impact factor: 3.710
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.